SCHEMBL25704333

SCHEMBL25704333

Cc1coc2c1C(O)C(=O)c1c-2ccc2c1CCCC2(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 5/20 0.65
▸ SUZ12 Q15022 5/20 0.65
▸ EZH2 Q15910 5/20 0.65
▸ MEN1 O00255 5/20 0.65
▸ ALDH1A1 P00352 5/20 0.65
▸ KMT2A Q03164 5/20 0.65
▸ CES2 O00748 4/20 0.65
▸ HPGD P15428 4/20 0.65
▸ HSD17B10 Q99714 4/20 0.65
▸ HIF1A Q16665 3/20 0.65
▸ EPAS1 Q99814 3/20 0.65
▸ KDM4E B2RXH2 3/20 0.65
▸ MAPT P10636 3/20 0.65
▸ RECQL P46063 3/20 0.65
▸ TDP1 Q9NUW8 3/20 0.65
▸ CES1 P23141 3/20 0.65
▸ POLB P06746 2/20 0.65
▸ PTPN6 P29350 2/20 0.65
▸ PTPN11 Q06124 2/20 0.65
▸ NSD1 Q96L73 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tanshinone Iia SCHEMBL2026738 0.79 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL29538928 0.75 EED (0.84) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL16023777 0.75 EED (0.84) EEDSUZ12EZH2MEN1ALDH1A1
Przewaquinone A SCHEMBL16152272 0.73 IDO1 (1.00) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL25704222 0.70 MEN1 (0.43) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL29539317 0.70 IDO1 (0.77) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL16152326 0.70 EED (0.78) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL20458614 0.69 CES1 (0.60) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL3718424 0.68 EED (0.58) EEDSUZ12EZH2MEN1ALDH1A1
Tanshinone Iib SCHEMBL14417728 0.67 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180034-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING NAPHTHOQUINONE-BASED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENTS NADIANBIO Ltd. (KR) 2023-05-17 — — EP disclosed
Send feedback